Skip to main content
Shree Ganesh Remedies Limited logo

Shree Ganesh Remedies Limited — Investor Relations & Filings

Ticker · 540737 ISIN · INE414Y01015 LEI · 335800KULR76L7DGZD23 BSE.NS Manufacturing
Open in API
Filings indexed 10 across all filing types
Latest filing 2026-05-25 Regulatory Filings
Country IN India
Listing BSE.NS 540737

About Shree Ganesh Remedies Limited

https://www.ganeshremedies.com/

Shree Ganesh Remedies Limited is a research-driven organization specializing in the development and manufacture of advanced intermediates and specialty chemicals. The company provides custom synthesis and contract manufacturing services (CRAMS), focusing on complex chemical reactions such as high-pressure hydrogenation, chlorination, and Grignard reactions. Its product portfolio supports various therapeutic applications, including anti-diabetic, anti-hypertensive, and anti-psychotic treatments. With a strong emphasis on research and development, the company offers scalable solutions from process design and pilot-scale production to full commercial manufacturing. The facilities are equipped with multi-purpose reactors and advanced analytical instrumentation to ensure compliance with international quality standards. By integrating process innovation with technical expertise, the company serves as a strategic partner for global life sciences and chemical entities.

Recent filings

Filing Released Lang Actions
Annual Secretarial Compliance Report for the year ended March 31, 2026
Regulatory Filings Classification · 87% confidence The document is an Annual Secretarial Compliance Report prepared by the Practicing Company Secretary and submitted to the stock exchange under SEBI LODR Regulation 24A. It is a compliance certificate/attestation rather than a full financial or management report. It does not contain substantive financial statements or strategic presentation data; it is a regulatory compliance filing. Under the guidelines, officer certifications and compliance attestations should be classified as a general regulatory filing. Therefore, the document is best classified as a Regulatory Filing (RNS).
2026-05-25 English
Transcript of Earnings Call
Report Publication Announcement Classification · 90% confidence The document is a brief exchange filing notifying the stock exchange that the transcript of the earnings conference call has been uploaded on the company’s website and provides a link. It does not contain the transcript itself, but rather announces the publication of that report. Under the “menu vs meal” rule, this is an announcement of a report’s release, fitting the Report Publication Announcement category (RPA).
2026-05-20 English
Audio Recording - Earnings Call held on May 15, 2026
Report Publication Announcement Classification · 82% confidence The document is a short notice to the stock exchange providing a link to the audio recording of an earnings call. It does not contain financial data or transcript, but merely announces publication of the audio. Under the “menu vs. meal” rule, this is an announcement of publication rather than the report itself, fitting the Report Publication Announcement category.
2026-05-16 English
Newspaper Publication
Earnings Release Classification · 75% confidence The document is a formal filing to the exchange enclosing the newspaper advertisement of audited financial results for the quarter and financial year ended March 31, 2026. It contains summary financial metrics (income, profit, EPS, ratios) rather than full financial statements. This aligns with an initial public announcement of periodical results (Earnings Release), not the complete interim report (IR) nor merely a publication notice (RPA). Therefore, it should be classified as an Earnings Release (ER). FY 2024
2026-05-15 English
Press Release
Earnings Release Classification · 85% confidence The document is a press release filed with BSE Limited announcing the audited financial results for Q4 and the full year ended March 31, 2026. It contains narrative commentary by the promoter and summary financial highlights (revenue, EBITDA, PAT, margins) rather than full financial statements, fitting the definition of an Earnings Release (initial announcement of periodical financial results). FY 2026
2026-05-15 English
Investor Presentation
Investor Presentation Classification · 93% confidence The document consists of a cover letter to the stock exchange enclosing a detailed slide deck titled “Investor Presentation Q4 & FY26” with quarterly and annual financial highlights, management commentary, P&L summary, balance sheet, cash flows, business overview, strategy, and investment merits. This clearly matches the definition of an Investor Presentation (Code: IP).
2026-05-14 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.